Telix Pharmaceuticals Limited Unsponsored ADR(TLX)
$9.73+0.28 (+2.91%)
TLX
Telix Pharmaceuticals Limited Unsponsored ADR Revenue
$9.73
At close:+0.28 (+2.91%)
Want to see TLX full AI Analyst Report?
Telix Pharmaceuticals Limited Unsponsored ADR (TLX) Revenue
14 Followers
Telix Pharmaceuticals Limited Unsponsored ADR Revenue
Telix Pharmaceuticals Limited Unsponsored ADR had a revenue of 476.04M in the quarter ending Jun 30, 2026, with 16.10%. This bring the company's revenue in the last twelve months to 886.07M, Increased 15.80%. In the fiscal year ending Dec 31, 2025, Telix Pharmaceuticals Limited Unsponsored ADR had annual revenue of 789.77M with 0.84% growth.
- Revenue (ttm)
- 886.07M
- Revenue Growth
- 33.78%
- P/S Ratio
- 4.07
- Revenue/Employee
- $685,565
- Employees
- 1,152
- Market Cap
- $3.22B
Revenue Chart
Telix Pharmaceuticals Limited Unsponsored ADR Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 789.77M | 6.56M | 0.84% |
| Dec 31, 2024 | 783.21M | 280.66M | 55.85% |
| Dec 31, 2023 | 502.55M | 342.45M | 213.90% |
| Dec 31, 2022 | 160.10M | 152.50M | 2007.64% |
| Dec 31, 2021 | 7.60M | 2.38M | 45.71% |
| Dec 31, 2020 | 5.21M | 1.73M | 49.58% |
| Dec 31, 2019 | 3.48M | 3.29M | 1685.88% |
| Dec 31, 2018 | 195.14K | 195.14K | ― |
| Dec 31, 2017 | 0.00 | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.